0001209191-23-032138.txt : 20230525 0001209191-23-032138.hdr.sgml : 20230525 20230525160502 ACCESSION NUMBER: 0001209191-23-032138 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230524 FILED AS OF DATE: 20230525 DATE AS OF CHANGE: 20230525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOHLIN GAREN G CENTRAL INDEX KEY: 0001254705 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 23960402 MAIL ADDRESS: STREET 1: C/O PRAECIS PHARMACEUTICALS INC STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-24 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001254705 BOHLIN GAREN G C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 1 0 0 0 0 Nonstatutory Stock Option (right to buy) 2.50 2023-05-24 4 A 0 34000 0.00 A 2033-05-23 Common Stock 34000 34000 D This option vests as to 100% of the underlying shares on May 24, 2024. /s/ Nancy Smith, Attorney-in-Fact for Garen Bohlin 2023-05-25